Answer
It may harm a developing baby, and its presence in breast milk is unknown. Pregnancy, contraception and breastfeeding require discussion with the oncology team before or during treatment.
Sources for this answer
- Rybrevant (amivantamab) 1600mg solution for injection — Current selected SmPCemc · Summary of Product Characteristics
- Rybrevant (amivantamab) 350mg concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics